Starting Wegovy is straightforward enough. Understanding what happens each time your dose goes up is a different matter – and that gap between expectation and reality is where most people get frustrated, second-guess themselves, or push through side effects they didn’t need to endure.
The standard schedule moves through four distinct dose increases over roughly 16 weeks before you reach the 2.4 mg maintenance level. Here’s a clear look at what each step actually involves.
The Jump from 0.25 mg to 0.5 mg
The 0.25 mg starting dose isn’t there to drive weight loss. It’s an acclimation period – four weeks for your body to get acquainted with semaglutide before the real work begins. Week five changes things fast, when the dose doubles to 0.5 mg. The Wegovy nausea duration at this stage typically runs one to three weeks as your gastrointestinal tract adjusts to a stronger hormonal signal. Nausea hits hardest in the hours right after an injection and tends to worsen with fatty, rich, or heavily spiced foods. Smaller portions, slower eating, and leaving a short gap between your injection and your next meal can all reduce severity noticeably. Appetite suppression also becomes real at this dose – most people report thinking about food less and feeling full well before they normally would. For many, this is the first week the medication actually feels like it’s doing something.
Weight loss at the 0.5 mg level is usually modest but measurable. A reduction of one to two pounds per week isn’t unusual, though some people see less at first. Don’t read too much into early fluctuations. Water retention and digestive changes can mask fat loss on the scale, so the trend over two to three weeks matters more than any single weigh-in. If nausea is severe enough to prevent you from eating normally, contact your prescribing doctor – dose pauses are a legitimate option and don’t mean you’ve failed the protocol.
The Step Up to 1.0 mg
Moving to 1.0 mg at week nine is when most people enter what clinicians consider the lower therapeutic range. Appetite suppression gets noticeably stronger. Many people describe a qualitative shift, not just eating less, but feeling genuinely indifferent to food in a way that’s unfamiliar. Cravings, especially for high-calorie comfort foods, often quiet down here. That shift is the GLP-1 receptor agonist acting on reward pathways in the brain, not just slowing stomach emptying. Nausea may briefly return after the dose increase, but it typically resolves faster than it did at 0.5 mg, since the body’s already built some tolerance to the mechanism. Fatigue and mild headaches are also reported at this step. They usually don’t last beyond the first week.
Weight loss tends to accelerate here. Clinical trial data from the STEP 1 trial, published in the New England Journal of Medicine in 2021, showed that participants on the full 2.4 mg dose lost an average of 14.9% of body weight over 68 weeks – and the trajectory toward that result typically steepens in the mid-dose range. At 1.0 mg, you’re in that steeper part of the curve. Blood sugar regulation also improves more meaningfully at this dose, which matters for anyone with prediabetes or insulin resistance. Track how you feel day-to-day rather than fixating solely on the scale. Energy levels, hunger patterns, and sleep quality all shift in ways that tell you the medication is working even before the numbers catch up.
Moving to 1.7 mg
At week 13, the dose steps up to 1.7 mg, and this is where some people hit their most challenging adjustment. The side effect profile at 1.7 mg tends to be more variable than at earlier steps. Some people move through it with minimal disruption. Others experience a return of nausea, new bouts of constipation, or a noticeable drop in energy in the days following the injection. Constipation becomes more common at higher doses because semaglutide slows gut motility; boosting fiber intake and fluid consumption in the days before and after your injection makes a real difference.
Appetite suppression at 1.7 mg is strong enough that some people struggle to eat adequate protein and vegetables, not because of nausea but because hunger signals become faint. This is a practical problem. Muscle mass is at risk if caloric intake drops too low, and adequate protein – most practitioners recommend 0.7 to 1.0 grams per pound of body weight – becomes harder to hit when you rarely feel hungry. Building intentional meal structure helps: eating on a schedule rather than waiting for hunger is a smarter strategy at this dose level. Many people also find that exercising – especially resistance training – helps manage constipation, supports muscle retention, and keeps energy levels more stable through the week.
Reaching the 2.4 mg Maintenance Dose
The 2.4 mg dose is the approved maintenance level, and it’s where most of the long-term clinical data sits. By week 17, you’ve had four months to build tolerance, refine eating habits, and figure out which side effects respond to which adjustments. For most people, the jump to 2.4 mg produces less disruption than earlier increases did, because the body’s adaptation to semaglutide is already well established. That said, some people find this final step brings GI symptoms back for a week or two. Consistent injection timing, good hydration, and controlled meal size all help minimize that recurrence.
Weight loss at 2.4 mg typically continues for several months before plateauing. The STEP 1 trial found that the greatest rate of weight loss occurred between weeks four and 20, with a plateau developing around week 60 to 68. If you’ve reached maintenance and your weight has stabilized, that’s the expected pattern, not a sign the medication has stopped working. Keeping that weight off still requires lifestyle support: regular physical activity, adequate sleep, and a diet built around protein and fiber rather than convenience. If 2.4 mg proves intolerable because of side effects, your doctor may keep you at 1.7 mg as a long-term dose; for some people, a lower maintenance level balances tolerability and results better than pushing to the maximum.
Each Wegovy dose increase builds on the last, and the side effects, appetite changes, and weight loss shifts you experience at each stage follow a predictable pattern once you know what to look for. Nausea tends to peak in the first two increases and ease from there. Weight loss accelerates through the mid-dose range. Appetite suppression deepens with each step. Knowing what to expect at each Wegovy dose increase puts you in a far better position to manage the adjustment rather than react to it – and to have a productive conversation with your doctor if something doesn’t feel right along the way.
